Decibel Cannabis Company (DB) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Achieved record net revenue of $35.6 million in Q2 2026, up 19% year-over-year, driven by strong international and domestic sales.
International sales surged 72% year-over-year to $10.6 million, reflecting improved German permit timelines and expanded product offerings in the UK.
Domestic sales grew 6% year-over-year to $25 million, supported by new product launches and strong brand performance.
Raised full-year 2026 outlook for net revenue to $132–$137 million and adjusted EBITDA to $28–$32 million.
Announced a 15:1 share consolidation and plans for a Normal Course Issuer Bid (NCIB) to enhance shareholder value.
Financial highlights
Gross margin before fair value adjustments improved to 51% in Q2 2026 from 47% in Q2 2025.
Record adjusted EBITDA of $7.8 million, up 24% year-over-year, primarily driven by international sales.
Free cash flow reached $4.9 million, a 122% increase year-over-year.
Adjusted net income was $4.2 million, up 23% year-over-year.
Adjusted EPS remained at $0.01 for the quarter.
Outlook and guidance
Full-year 2026 net revenue guidance raised to $132–$137 million from $130–$135 million.
Adjusted EBITDA guidance increased to $28–$32 million from $27–$31 million.
International sales expected to maintain high double-digit growth through 2026.
Domestic sales anticipated to achieve high single-digit growth for the year.
Latest events from Decibel Cannabis Company
- Strong revenue growth, profitability, and global expansion drive 2026 outlook.DB
Investor presentation - International expansion and strong margins drive double-digit growth outlook for 2024.DB
Planet MicroCap Las Vegas 2026 - Q3 2025 net revenue rose 37% to $32.9M, with strong international growth and revised 2025 guidance.DB
Q3 2025 - Strong revenue growth and profitability position the company for accelerated global expansion in 2026.DB
Investor presentation - Q1 2026 revenue rose 41%, with record international sales and doubled adjusted EBITDA.DB
Q1 2026 - Accelerating international growth and profitability with AgMedica acquisition and strong 2025 outlook.DB
Investor presentation - Strong 2025 results and global expansion position the company for accelerated growth in 2026.DB
Investor presentation - Revenue rose 22% to CAD 113 million, fueled by nearly 5x international sales growth.DB
Q4 2025 - Gross margin rose to 53% as Decibel shifted focus to global markets and improved free cash flow.DB
Q3 2024